Anti-CD19 Antikörper (A323388)

Name: Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free
Brand: Antibodies.com
SKU: A323388
Price: 295.0 USD
Availability: InStock

Bild Vergrößern

$295

Monoklonal Humanized Antikörper gegen CD19 für ELISA, FACS, Functional Assay und In Vivo.

100% Qualitätsgarantie

Preis-Match-Garantie

Versand

Versandkosten

$40

Vorlaufzeit

Lieferung in 7-10 Werktagen

Kontakt

Telefon

+1 (314) 370-6046

orders@antibodies.com

Garantien

100% Qualitätsgarantie

Preis-Match-Garantie

Stichworte:

Rekombinant Antikörper

Produktdetails

Produktname

Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free

Beschreibung

Recombinant humanized monoclonal antibody to CD19.

Anwendungen

ELISA, FACS, Functional Assay, In Vivo

Reaktivität

Human

Wirt

Humanized

Klonalität

Monoclonal

Isotyp

IgG1

Leichte Ketten

kappa

Konjugat

Unconjugated

Reinigung

Protein A affinity chromatography.

Konzentration

Reconstitution dependent.

Molekulargewicht

This antibody has a predicted MW of 145 kDa.

Reinheit

> 95% (by SDS-PAGE and SEC-HPLC).

Produktform

Lyophilized

Rekonstitution

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Formulierung

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Lagerung

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Synonyme

Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B4, CD19 antigen, CD19 molecule, Cd19 protein, CD19_HUMAN, CVID3, Differentiation antigen CD19, Leu 12, Leu-12, Leu12, MGC109570, MGC12802, T-cell surface antigen Leu-12

Kompatible Sekundärantikörper

Haftungsausschluss

Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.

Produktbilder (2)

Bild Vergrößern

Figure 1: SDS-PAGE - Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323388)

SDS-PAGE analysis of Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323388) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.

Bild Vergrößern

Figure 2: Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323388)

SEC-HPLC analysis of Denintuzumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323388) confirms that the purity of this antibody is 100%.